Identified novel DYSF mutations in Italian patients with dysferlinopathy, though genotype-phenotype correlation remained unclear.
Answers are grounded in this paper and cite their sources.
Novel DYSF variants expand the Italian dysferlinopathy spectrum; leaves open genotype-phenotype correlations and should not yet alter practice.
Mutations in the dysferlin gene (DYSF) on chromosome 2p13 cause distinct phenotypes of muscular dystrophy: limb-girdle muscular dystrophy type 2B (LGMD2B), Miyoshi myopathy (MM), and distal anterior compartment myopathy, which are known by the term 'dysferlinopathy'. We performed mutation analyses of DYSF in 14 Italian patients from 10 unrelated families with a deficiency of dysferlin protein below 20% of the value in normal controls by immunoblotting analysis. We identified 11 different mutations, including eight missense and three deletion mutations. Nine of them were novel mutations. We also identified a unique 6-bp insertion polymorphism within the coding region of DYSF in 15% of Italian population, which was not observed in East Asian populations. The correlation between clinical phenotype and the gene mutations was unclear, which suggested the role of additional genetic and epigenetic factors in modifying clinical symptoms.
No takes yet. Share an insight, caveat, or question.
Kawabe et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: